Revenue: The sum of all revenue fields included for a company's operating activities.
Talis Biomedical Corporation (TLIS) Revenue data is not available for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-8.85M |
|
-- |
|
-- |
|
$9.58M |
|
$-9.58M |
|
$0.73M |
|
$-8.85M |
|
$-8.85M |
|
$-8.85M |
|
$-8.85M |
|
$-8.85M |
|
$-8.85M |
|
$-9.58M |
|
$-9.49M |
|
1.82M |
|
1.82M |
|
$-4.86 |
|
$-4.86 |
|
| Balance Sheet Financials | |
$63.60M |
|
$0.42M |
|
$9.10M |
|
$72.70M |
|
$8.20M |
|
-- |
|
$15.88M |
|
$24.07M |
|
$48.62M |
|
$48.63M |
|
$48.63M |
|
1.82M |
|
| Cash Flow Statement Financials | |
$-17.76M |
|
$0.11M |
|
$0.00M |
|
$78.27M |
|
$60.63M |
|
$-17.64M |
|
$1.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.20% |
|
-18.20% |
|
-12.17% |
|
-18.20% |
|
$26.69 |
|
$-9.68 |
|
$-9.74 |
|